These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. Comunale MA; Wang M; Hafner J; Krakover J; Rodemich L; Kopenhaver B; Long RE; Junaidi O; Bisceglie AM; Block TM; Mehta AS J Proteome Res; 2009 Feb; 8(2):595-602. PubMed ID: 19099421 [TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead. Giannini EG; Farinati F; Trevisani F Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475 [No Abstract] [Full Text] [Related]
4. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment. Trojan J; Raedle J; Zeuzem S Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428 [No Abstract] [Full Text] [Related]
5. Hope for a cure through earlier detection of hepatocellular cancer. Sitzmann JV Ann Surg Oncol; 1999 Mar; 6(2):133-4. PubMed ID: 10082034 [No Abstract] [Full Text] [Related]
6. Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment. Kawakami T; Hoshida Y; Kanai F; Tanaka Y; Tateishi K; Ikenoue T; Obi S; Sato S; Teratani T; Shiina S; Kawabe T; Suzuki T; Hatano N; Taniguchi H; Omata M Proteomics; 2005 Nov; 5(16):4287-95. PubMed ID: 16254924 [TBL] [Abstract][Full Text] [Related]
7. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma. Wang C; Ren T; Wang K; Zhang S; Liu S; Chen H; Yang P Sci China Life Sci; 2017 Sep; 60(9):1047-1050. PubMed ID: 28547580 [No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma. Yang XR; Guo W Ann Surg Oncol; 2019 Dec; 26(Suppl 3):529-530. PubMed ID: 30519762 [No Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma tumour markers: current role and expectations. Rich N; Singal AG Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312 [TBL] [Abstract][Full Text] [Related]
10. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma. Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095 [No Abstract] [Full Text] [Related]
11. Serum alpha 1-antitrypsin in patients with hepatocellular carcinoma. Lee HB; Yoo OJ; Ham JS; Lee MH Clin Chim Acta; 1992 Mar; 206(3):225-30. PubMed ID: 1376649 [TBL] [Abstract][Full Text] [Related]
12. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma. Han N; Wang W; Lu D; Wang H; Ma X; Fan X; Li F Chem Commun (Camb); 2017 Nov; 53(90):12209-12212. PubMed ID: 29077109 [TBL] [Abstract][Full Text] [Related]
15. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction. Aoyagi Y; Tamura Y; Suda T J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297 [No Abstract] [Full Text] [Related]
16. Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma. He J; Liu Y EBioMedicine; 2016 Oct; 12():4-5. PubMed ID: 27665049 [No Abstract] [Full Text] [Related]
17. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma. Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140 [TBL] [Abstract][Full Text] [Related]
19. Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma. Kuromatsu R; Tanaka M; Tanikawa K Liver; 1993 Aug; 13(4):177-82. PubMed ID: 7690873 [TBL] [Abstract][Full Text] [Related]
20. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma]. Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775 [No Abstract] [Full Text] [Related] [Next] [New Search]